TSXV:TRL.H - Post by User
Comment by
LTOWNERon Sep 16, 2013 1:04pm
204 Views
Post# 21743072
RE:He was in Biovail as well
RE:He was in Biovail as well Nice catch fingersdk. Ihnatowycz was formerly a health-care analyst, holds a degree in pharmacology with post grad work in medical science, plus an MBA. He made an early discovery of Biovail Corp. International which subsequently achieved "exceptionally strong earnings growth" before being acquired by Valeant Pharma. He has obviously invested heavily in Trimel and joined it's Board due to optimism in the company's prospects. He will be familiar with the founders of Trimel, who also founded Biovail.
Ihnatowycz is a value-based investor; looks for long-term value and growth, reasonably priced companies with strong management holding a significant ownership position, at least for his socially responsible investments.